Polycystic Ovary Syndrome: vanity or something more important? - On Demand
- $60.00 incl. GST for PSNZ members
- $180.00 incl. GST for non-members
About the product
About this learning module;
This learning consists of a 2-hour webinar, supplementary readings and a multichoice assessment to test your knowledge.
This learning activity has been accredited by PSNZ Education (Professional Development and Training) for 3 hours of professional learning and is suitable for inclusion in a pharmacist’s records for Continuing Professional Development (CPD) purposes.
This learning can be used for your annual recertification requirements -
O1.1 Consult with the patient, O1.2 Provide healthcare, O1.4 Deliver quality and safe services, O1.5 Access, evaluate and provide medicines information, O2.1 Contribute to community health, O3.1 Assess prescriptions, O3.5 Provide patient counselling.
Presented by: Dr Anna Fenton
Dr Fenton is a Gynaecological Endocrinologist. She is currently the clinical leader for the Canterbury District Health Board Bone Density Service. Anna is actively involved in both undergraduate and postgraduate teaching. She has special interests in the management of premature ovarian insufficiency and the treatment of women after gynaecological cancer. She ran the Gynae-Endocrine clinic at Christchurch Women’s Hospital for 15 years which provides one of the few publicly funded clinics for women with polycystic ovary syndrome. She also serves on the PTAC Endocrine sub-committee.
This webinar was recorded on:
4 December 2018, reviewed and updated October 2020 and December 2022.
Learning Objectives and Competence Standards
On completion of this course, participants will be able to:
- Explain the pathogenesis of PCOS
- Describe the criteria for diagnosing PCOS
- Recognise the different presentations of PCOS
- Explain the variety of evidence-based treatment options available to manage PCOS